Success Metrics

Clinical Success Rate
88.0%

Based on 117 completed trials

Completion Rate
88%(117/133)
Active Trials
15(9%)
Results Posted
50%(58 trials)
Terminated
16(9%)

Phase Distribution

Ph phase_4
35
20%
Ph phase_3
44
26%
Ph phase_1
19
11%
Ph phase_2
42
24%
Ph not_applicable
20
12%

Phase Distribution

19

Early Stage

42

Mid Stage

79

Late Stage

Phase Distribution160 total trials
Phase 1Safety & dosage
19(11.9%)
Phase 2Efficacy & side effects
42(26.3%)
Phase 3Large-scale testing
44(27.5%)
Phase 4Post-market surveillance
35(21.9%)
N/ANon-phased studies
20(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.8%

117 of 138 finished

Non-Completion Rate

15.2%

21 ended early

Currently Active

15

trials recruiting

Total Trials

172

all time

Status Distribution
Active(21)
Completed(117)
Terminated(21)
Other(13)

Detailed Status

Completed117
Terminated16
Recruiting15
unknown13
Not yet recruiting5
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
172
Active
15
Success Rate
88.0%
Most Advanced
Phase 4

Trials by Phase

Phase 119 (11.9%)
Phase 242 (26.3%)
Phase 344 (27.5%)
Phase 435 (21.9%)
N/A20 (12.5%)

Trials by Status

not_yet_recruiting53%
recruiting159%
terminated169%
unknown138%
withdrawn53%
completed11768%
enrolling_by_invitation11%

Recent Activity

Clinical Trials (172)

Showing 20 of 172 trialsScroll for more
NCT05450978

Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding

Recruiting
NCT06866691Phase 4

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed
NCT01345058Phase 3

Add on Lacosamide Versus High Dose Monotherapy

Completed
NCT07490769Phase 3

Levetiracetam Three Times Daily in Epilepsy

Recruiting
NCT06345495Phase 2

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

Recruiting
NCT06442748Phase 3

Short Versus Long-term Levetiracetam in Brain Tumors

Recruiting
NCT07401433Not Applicable

Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.

Completed
NCT07284498Phase 4

Treatment of Seizures in Neonate With HIE

Not Yet Recruiting
NCT07239115Phase 3

Levetiracetam for Seizure Prevention After Brain Tumor Surgery

Not Yet Recruiting
NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed
NCT06081283Phase 4

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

Terminated
NCT04833907Phase 1

rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease

Enrolling By Invitation
NCT07220902Phase 3

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

Not Yet Recruiting
NCT07163585Not Applicable

Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy

Completed
NCT07072624Phase 4

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Recruiting
NCT05735717Phase 2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Recruiting
NCT03034356Phase 1

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Completed
NCT07052136Not Applicable

Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus

Completed

Drug Details

Intervention Type
DRUG
Total Trials
172